angiotensin II Giapreza
Selected indexed studies
- Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory Shock. (Cardiol Rev, 2019) [PMID:30601161]
- The renin-angiotensin-aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II. (Crit Care, 2024) [PMID:39593182]
- Angiotensin II (Giapreza) for septic shock. (Med Lett Drugs Ther, 2018) [PMID:30653477]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory Shock. (2019) pubmed
- The renin-angiotensin-aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II. (2024) pubmed
- Angiotensin II (Giapreza) for septic shock. (2018) pubmed
- Angiotensin II-generating enzymes. (2000) pubmed
- Angiotensin II in the carotid body - a friend or foe? (2016) pubmed
- The angiotensin II receptor and the actions of angiotensin II. (1990) pubmed
- Angiotensin II Blockade. (1977) pubmed
- Angiotensin II and skeletal muscle abnormalities. (2017) pubmed
- Angiotensin II and aldosterone regulation. (1999) pubmed
- Angiotensin I, angiotensin II and their biologically active peptides. (2002) pubmed